FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results